Tokyo/Osaka, Japan
Wilson Sonsini is pleased to sponsor the 2025 US-Japan Healthcare Innovation Conference.
Originally launched in 2014, the US-Japan Healthcare Innovation Conference is dedicated to driving innovation in the healthcare sectors of the US and Japan by bringing together leaders in the life sciences industry, government, and academia to discuss the latest trends and topics that are changing the face of healthcare.
This year’s theme is: How AI and Science are Driving the Future of Medicine: Advancing US-Japan Healthcare Collaboration From Kansai to the World.
This event draws hundreds of attendees from the private, public, and academic sectors in Japan. Past attendees have included representatives from companies such as CMIC, Hoya, Kaneka, Mitsubishi Corp., NIPRO, Otsuka, Ricoh, Sumitomo, Takeda, Terumo, UTEC, and many more, as well as government agencies including AMED. JETRO, MHLW, METI, and others.
On September 16th at 12:50pm in Tokyo, partner Seth Flaum will participate in the panel discussion, Impact of AI on Life Science Innovation. At 3:50pm on September 16th in Tokyo, partner Elton Satusky will moderate the panel session, Building Global Enterprises in Life Sciences – US and Japan Approaches. On September 19th in Osaka, at 10:15am, partner Seth Flaum will participate in the panel discussion, Impact of AI on Life Science Innovation. At 2:30pm on September 19th in Osaka, partner Elton Satusky will moderate the panel session, Building Global Enterprises in Life Sciences – US and Japan Approaches.
The conference is organized by the US-Japan Healthcare Connection (www.usjhealthcare.org) a collaborative initiative of the Japan Society of Northern California (JSNC) and US-Japan Medtech Frontiers (USJMF), two organizations dedicated to promoting cooperation and understanding between the US and Japan. Our partners and co-organizers for this year’s event are LINK-J Japan, and Osaka University.
To learn more about the event scheduled sessions, please visit the event website.
Norilyn Ingram
ningram@wsgr.com
Elton specializes in public and private corporate finance and corporate law and governance. He also has considerable M&A and venture capital experience.
Seth Flaum is a partner in the New York office of Wilson Sonsini Goodrich & Rosati, where he is a member of the technology transactions practice. With more than 25 years of broad transactional experience, he represents life sciences companies in a wide range of strategic transactions and corporate matters.